T cell regeneration after allogeneic bone marrow transplantation
- PMID: 6352107
- PMCID: PMC1536173
T cell regeneration after allogeneic bone marrow transplantation
Abstract
Various T cell subsets were characterized by double immunofluorescent staining using monoclonal antibodies (MoAb) in blood, bone marrow (BM) and tissues of 29 patients after allogeneic BM transplantation (BMT). In an attempt to prevent graft versus host disease (GvHD), 15 patients received cyclosporin A (Cy A). In the remaining 14 patients the BM was pre-incubated with a MoAb, OKT3. The regeneration of T4+ subset was delayed and the level of T8+ cells was abnormally high even 1 year after engraftment. This did not have any predictive value for the appearance of complications such as GvHD or severe viral infections. The number of T8+ cells was lower in the group of patients who received Cy A than in the OKT3 group (0.7 +/- 0.2 vs 1.5 +/- 0.3 X 10(9)/1 at day 90). In contrast to normal individuals, the T4/T8 ratio in both blood and regenerating BM of BMT patients was less than 1. A sizeable subset of circulating T cells expressed the phenotype T8+, T10+, HNK-1+, DR+. Circulating cells of this phenotype were transiently very high (up to 50%) in patients with active GvHD or suffering from severe viral infection. This subpopulation of lymphocytes was not found in the epidermal infiltrate that accompanied GvHD where the predominant phenotype was T8+, T1-, T10-, HNK-1-, DR-. We conclude therefore that after BMT the number and phenotype of circulating T cells reflects the T cell distribution seen in the regenerating BM.
Similar articles
-
T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow.Clin Exp Immunol. 1986 Mar;63(3):577-86. Clin Exp Immunol. 1986. PMID: 3011326 Free PMC article.
-
The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation.Clin Exp Immunol. 1985 Nov;62(2):278-87. Clin Exp Immunol. 1985. PMID: 3002684 Free PMC article.
-
Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies.Bone Marrow Transplant. 1995 Jun;15(6):891-4. Bone Marrow Transplant. 1995. PMID: 7581087 Clinical Trial.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Monoclonal antibodies in the diagnosis and treatment of childhood diseases.Adv Pediatr. 1985;32:101-37. Adv Pediatr. 1985. PMID: 3909771 Review. No abstract available.
Cited by
-
Cyclosporin A and doxorubicin-ifosfamide in resistant solid tumours: a phase I and an immunological study.Br J Cancer. 1995 Nov;72(5):1294-9. doi: 10.1038/bjc.1995.503. Br J Cancer. 1995. PMID: 7577485 Free PMC article. Clinical Trial.
-
Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children.Korean J Hematol. 2012 Mar;47(1):44-52. doi: 10.5045/kjh.2012.47.1.44. Epub 2012 Mar 28. Korean J Hematol. 2012. PMID: 22479277 Free PMC article.
-
Pulmonary cell populations in recipients of bone marrow transplants with interstitial pneumonitis.Thorax. 1989 Jul;44(7):570-5. doi: 10.1136/thx.44.7.570. Thorax. 1989. PMID: 2672406 Free PMC article.
-
CD5-positive B cells after T cell depleted bone marrow transplantation.Clin Exp Immunol. 1987 Jun;68(3):662-8. Clin Exp Immunol. 1987. PMID: 3308220 Free PMC article.
-
An immunohistological study of human hepatic graft-versus-host disease.Clin Exp Immunol. 1985 Dec;62(3):545-53. Clin Exp Immunol. 1985. PMID: 3910317 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials